<DOC>
	<DOCNO>NCT02766517</DOCNO>
	<brief_summary>This study participants diagnosis migraine complete another clinical trial know I5Q-MC-CGAB ( CGAB ) ( NTC02163993 ) . In CGAB , participants receive either LY2951742 placebo . This study evaluate certain biomarkers may relate participant 's response CGAB . The study last five day .</brief_summary>
	<brief_title>Biomarker Study Participants With Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Participants migraine previously participate study I5QMCCGAB receive one select dose LY2951742 placebo Have suitable skin characteristic dermal capsaicin challenge Have history significant allergy , particular ethanol sensitivity fruit capsicum plant ( example , chili pepper ) Have eczema , scleroderma , psoriasis , dermatitis , keloid , tumor , ulcer , burn , flap , graft forearm abnormality skin may interfere study assessment Can avoid excess tanning ( exposure sunlight tan bed would cause sunburn reaction ) throughout study cover forearm 24 hour prior treatment period Have excessive hair growth volar surface forearm participant currently use lotion , oil , depilatory preparation , topical treatment regular basis discontinue duration study ; use topical treatment within 7 day start study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>